
Teladoc (TDOC) Stock Forecast & Price Target
Teladoc (TDOC) Analyst Ratings
Bulls say
Teladoc Health has demonstrated promising signs of recovery with sequential membership growth in its BetterHelp segment and the onboarding of 800 new clients in Integrated Care, indicating a revitalization in its customer base. Additionally, the Chronic Care program has seen an increase in enrollment, reaching approximately 1.203 million, which reflects a year-over-year growth of 4%, highlighting the increasing utilization of Teladoc’s services. Furthermore, the company’s ability to manage expenses has resulted in a fourth-quarter GAAP EPS loss that was significantly better than anticipated, bolstering the overall outlook for growth in a market poised for expansion.
Bears say
Teladoc Health has experienced a 3.0% year-over-year decline in total revenue, primarily attributed to a 9.5% decrease in the BetterHelp segment, which accounted for a significant portion of its overall earnings. The company's Integrated Care segment showed modest growth of 1.6%, but this was insufficient to offset the contraction in BetterHelp, raising concerns about overall profitability and growth prospects. Additionally, a continuous decline in BetterHelp users for five consecutive quarters and management's cautious profit outlook, influenced by challenges stemming from the Catapult acquisition, further contributes to a negative financial outlook for Teladoc Health.
This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.
Teladoc (TDOC) Analyst Forecast & Price Prediction
Start investing in Teladoc (TDOC)
Order type
Buy in
Order amount
Est. shares
0 shares